Yagnasri Eagala
NPI: 1801250774
Total Payments
$1,892
2024 Payments
$889.83
Companies
19
Transactions
106
Medicare Patients
1,080
Medicare Billing
$95,039
Payment Breakdown by Category
Food & Beverage$1,892 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,892 | 106 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $529.27 | 29 | $0 (2024) |
| PFIZER INC. | $311.76 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $238.70 | 11 | $0 (2024) |
| Novo Nordisk Inc | $203.98 | 12 | $0 (2024) |
| Gilead Sciences, Inc. | $103.35 | 5 | $0 (2024) |
| Lilly USA, LLC | $82.63 | 5 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $73.41 | 4 | $0 (2022) |
| Smith+Nephew, Inc. | $50.36 | 3 | $0 (2024) |
| Lundbeck LLC | $47.48 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $44.84 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $889.83 | 48 | AstraZeneca Pharmaceuticals LP ($171.78) |
| 2023 | $482.81 | 27 | GlaxoSmithKline, LLC. ($203.34) |
| 2022 | $487.77 | 29 | GlaxoSmithKline, LLC. ($168.58) |
| 2021 | $31.75 | 2 | GlaxoSmithKline, LLC. ($31.75) |
All Payment Transactions
106 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.94 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.03 | General |
| 11/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: PAIN | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/13/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Pharma Products | ||||||
| 08/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Diabetes Care | ||||||
| 08/07/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: RESPIRATORY | ||||||
| 07/24/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: VACCINES | ||||||
| 07/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Inflammation | ||||||
| 06/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.15 | General |
| 05/29/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Inflammation | ||||||
| 05/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.96 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 323 | 415 | $68,741 | $30,378 |
| 2022 | 5 | 284 | 360 | $58,809 | $26,929 |
| 2021 | 4 | 247 | 271 | $46,173 | $22,375 |
| 2020 | 5 | 226 | 263 | $36,018 | $15,357 |
Total Patients
1,080
Total Services
1,309
Medicare Billing
$95,039
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 110 | 110 | $23,650 | $13,917 | 58.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 151 | $25,652 | $9,428 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 94 | $11,310 | $4,025 | 35.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 18 | 28 | $5,342 | $2,048 | 38.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,493 | $832.56 | 33.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 20 | 21 | $294.00 | $127.60 | 43.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 103 | 103 | $21,302 | $13,251 | 62.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 138 | $24,443 | $9,134 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 96 | $12,043 | $4,208 | 34.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $853.60 | $257.29 | 30.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 12 | 12 | $168.00 | $78.09 | 46.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 107 | 107 | $22,898 | $13,880 | 60.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 84 | $9,878 | $4,042 | 40.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 54 | $9,029 | $3,691 | 40.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 25 | 26 | $4,368 | $760.95 | 17.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 41 | 41 | $8,159 | $4,647 | 57.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 57 | 74 | $11,011 | $4,252 | 38.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 83 | 98 | $10,163 | $3,621 | 35.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 30 | 35 | $4,477 | $2,071 | 46.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 15 | 15 | $2,208 | $764.84 | 34.6% |
About Yagnasri Eagala
Yagnasri Eagala is a Student in an Organized Health Care Education/Training Program healthcare provider based in Utica, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2016. The National Provider Identifier (NPI) number assigned to this provider is 1801250774.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Yagnasri Eagala has received a total of $1,892 in payments from pharmaceutical and medical device companies, with $889.83 received in 2024. These payments were reported across 106 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,892).
As a Medicare-enrolled provider, Eagala has provided services to 1,080 Medicare beneficiaries, totaling 1,309 services with total Medicare billing of $95,039. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Location Utica, NY
- Active Since 04/07/2016
- Last Updated 06/22/2016
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1801250774
Products in Payments
- TRELEGY ELLIPTA (Drug) $398.22
- NURTEC ODT (Drug) $152.44
- Rybelsus (Drug) $143.54
- ELIQUIS (Drug) $129.42
- AIRSUPRA (Drug) $125.35
- FARXIGA (Drug) $98.49
- REXULTI (Drug) $92.32
- SHINGRIX (Biological) $92.31
- MOUNJARO (Drug) $65.95
- PREVNAR 20 (Biological) $56.06
- AREXVY (Drug) $38.74
- FREESTYLE LIBRE 2 (Device) $38.30
- REGRANEX (Drug) $35.45
- Ozempic (Drug) $32.95
- Otezla (Drug) $29.51
- COMIRNATY (Biological) $24.75
- TRUMENBA (Biological) $22.50
- JARDIANCE (Drug) $16.68
- MAVYRET (Drug) $16.46
- TRINTELLIX (Drug) $16.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Utica
Dr. Ibrahim Elkilany, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $8,032
Student in an Organized Health Care Education/Training Program $8,032
Mr. Colin Wright, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $7,991
Student in an Organized Health Care Education/Training Program $7,991
Stephen Chruscicki
Student in an Organized Health Care Education/Training Program — Payments: $4,780
Student in an Organized Health Care Education/Training Program $4,780
Manu Arul, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $2,101
Student in an Organized Health Care Education/Training Program $2,101
Rashid Girshab, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $1,776
Student in an Organized Health Care Education/Training Program $1,776
Molly Taft, Pa-C, PA-C
Student in an Organized Health Care Education/Training Program — Payments: $1,224
Student in an Organized Health Care Education/Training Program $1,224